Faeth Therapeutics, Inc. (FTH)
CIK 1829802 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Faeth Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Nov 3, 2026 | 10-Q | 0001193125-26-444376 |
| Nov 3, 2026 | S-8 | 0001193125-26-444421 |
| Nov 3, 2026 | 4 | 0002111813-26-000013 |
| Nov 3, 2026 | 8-K | 0001193125-26-444410 |
| Oct 27, 2026 | 3 | 0002127119-26-000008 |
| Oct 27, 2026 | 8-K | 0001193125-26-432688 |
| Oct 27, 2026 | 4 | 0002127119-26-000009 |
| Sep 17, 2026 | 8-K | 0001193125-26-394360 |
| Sep 15, 2026 | 3 | 0001723884-26-000004 |
| Sep 15, 2026 | 4 | 0001723884-26-000005 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001493152-26-038381 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001104659-26-096753 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001727492-26-000018 |
| Aug 14, 2026 | SCHEDULE 13G | 0001193125-26-352288 |
| Aug 11, 2026 | 144 | 0001959173-26-005879 |
| Aug 4, 2026 | 8-K | 0001193125-26-331563 |
| Aug 4, 2026 | 10-Q | 0001193125-26-331562 |
| Jul 28, 2026 | 3 | 0001193125-26-321026 |
| Jul 23, 2026 | 4 | 0002111813-26-000012 |
| Jul 23, 2026 | 4 | 0002038400-26-000004 |
| Jul 23, 2026 | 8-K | 0001193125-26-314591 |
| Jul 1, 2026 | 4 | 0001780030-26-000006 |
| Jun 26, 2026 | 4 | 0001780030-26-000005 |
| Jun 24, 2026 | 4 | 0002111813-26-000010 |
| Jun 24, 2026 | 4 | 0001780030-26-000004 |